http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Lupin and AbbVie Announce Partnership to Develop and Commercialize Novel Oncology Drug to Treat Hematological Cancers
-
Lupin Neurosciences Announces Positive CHMP Opinion for NaMuscla™ for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders
-
Lupin Acquires Symbiomix Therapeutics LLC
-
Lupin Receives FDA Approval for Generic Nuvigil® Tablets
-
Lupin Bolsters US Brands Portfolio with Methergine® Oral Tablets
-
Lupin Appoints Dr. Kurt Nielsen as President of Lupin - Somerset
-
Lupin Launches Generic Intermezzo® Sublingual Tablets in the US
-
Lupin Completes its Acquisition of GAVIS
-
Lupin Launches Generic Glumetza® HCI ER Tablets in the US
-
Lupin Launches Generic Ortho Tri-Cyclen® Lo Tablets in the US
-
Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)
-
Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US
-
Lupin Announces New Center of Excellence for Inhalation Research in Florida
-
Lupin Acquires Specialty Product Portfolio in Germany
-
Lupin Acquires GAVIS to Expand US Generic Business
-
Lupin Acquires GAVIS to Expand US Generic Business
-
Lupin Acquires Biocom in Russia
-
Lupin Launches Zaxine® in Canada

